Gobierno de Navarra

The Gobierno de Navarra, through its affiliated institutions like the Hospital Universitario de Navarra (HUN) and the Cancer Center Clínica Universidad de Navarra, is currently in the news due to two distinct developments. Firstly, toxicology experts at HUN are investigating the death of a young person in 2024, potentially linked to the consumption of a nitazene variant, a high-risk synthetic opioid. This investigation is significant as it could represent the first death in Spain attributed to this specific opioid. Secondly, scientists at the Cancer Center Clínica Universidad de Navarra have developed an experimental cancer treatment combining radiotherapy and gene therapy, showing promising results in animal models for various solid tumors. This research, published in Cancer Cell, highlights the Gobierno de Navarra's involvement in cutting-edge medical research and its potential impact on cancer treatment strategies.